HOOKIPA PHARMA INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.8933 USD | +10.82% |
|
+21.87% | +10.28% |
| Apr. 25 | Transcript : HOOKIPA Pharma Inc. - Special Call | |
| Apr. 25 | HOOKIPA Pharma Inc. Announces Pivotal Phase 2/3 Trial Design for HB-200 in Combination with Pembrolizumab | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Neutral |
| Resistance | 0.9150 | 1.160 | 1.040 |
| Spread/Res. | -2.37% | -22.99% | -14.11% |
| Spread/Supp. | +10.30% | +39.56% | +107.74% |
| Support | 0.8099 | 0.6401 | 0.4300 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- HOOK Stock
- Charts HOOKIPA Pharma Inc.
